chartexchange

Ultragenyx to Participate at Investor Conferences in London

GlobeNewswire Inc. | Nov 11, 2026 8:30 AM EST

NOVATO, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced participation in upcoming investor conferences.

Read original article